Nutex Health Reports Significant Net Income Growth for First Nine Months of 2026
Nutex Health (NUTX) reported strong profitability for the first nine months of 2026, highlighted by a 159% increase in net income to $152.9 million. This surge was primarily driven by a substantial reduction in stock-based compensation and contract service expenses as legacy facilities completed their earn-out periods. While total revenue saw a 10.9% year-over-year decrease to $644.9 million due to historical collection adjustments, the company's bottom line benefited significantly from improved cost management. Operational metrics showed resilience, with hospital division visits increasing by 10.2% and population health revenue growing by 14%. The company also maintained a high success rate in independent dispute resolution (IDR), boasting an over 80% win rate on award determinations. With cash and cash equivalents rising to $249.9 million, Nutex Health appears well-positioned for continued expansion despite slight decreases in adjusted EBITDA.
Tickers: $AAPL $AMZN $GOOG $META $MSFT $NUTX $NVDA $TSLA
Topics: cash flow eps hospital visits net income revenue